Who should not take PNC-27?
Documented caution flags for PNC-27 include anyone without medical oversight and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for PNC-27 is limited.
Documented caution flags for PNC-27
- Anyone without medical oversight
- Pregnancy / nursing
- Active autoimmune conditions
Reported side effects to weigh
- Limited human safety data
- Theoretical off-target membrane effects
- Injection-site reaction
References
- PNC-27, anticancer peptide that selectively kills HDM-2-expressing cancer cells — Michl J et al., Anticancer Res, 2006
- Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption — Krzesaj P et al., Annals of Clinical and Laboratory Science, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PNC-27
Last updated 2026-06-15.